The Library
Reactions of an organoruthenium anticancer complex with 2-mercaptobenzanilide — a model for the active-site cysteine of protein tyrosine phosphatase 1B
Tools
Han, Yumiao, Luo, Qun, Hao, Xiang, Li, Xianchan, Wang, Fuyi, Hu, Wenbing, Wu, Kui, Lü, Shuang and Sadler, P. J.. (2011) Reactions of an organoruthenium anticancer complex with 2-mercaptobenzanilide — a model for the active-site cysteine of protein tyrosine phosphatase 1B. Dalton Transactions, Vol.40 (No.43). pp. 11519-11529. ISSN 1477-9226
|
Text
WRAP_Sadler_475_DaltonTrans_revised manuscript.pdf - Accepted Version Download (1364Kb) | Preview |
Official URL: http://dx.doi.org/10.1039/C1DT11189B
Abstract
The organometallic anticancer complex [(η6-p-cymene)Ru(en)Cl]PF6 (1, en = ethylenediamine) readily reacts with thiols and forms stable sulfenate/sulfinate adducts which may be important for its biological activity. Protein tyrosine phosphatase 1B (PTP1B), a therapeutic target, contains a catalytic cysteinyl thiol and is involved in the regulation of insulin signaling and the balance of protein tyrosine kinase activity. On oxidation, the catalytic Cys215 can form an unusual sulfenyl-amide intermediate which can subsequently be reduced by glutathione. Here we study reactions of 1 with 2-mercaptobenzanilide, 2, a recognized model for the active site of PTP1B. We have characterized crystallographically compound 2 and its oxidized sulfenyl-amide derivative 2-phenyl-1,2-benzisothiazol-3(2H)-one (4), which shows a close structural similarity to the sulfenyl-amide in oxidized PTP1B. At pH 7.4 and 5.3, 1 reacted with 2, affording a mono-ruthenium thiolato complex [(η6-cym)Ru(en)(S-RS)]+ (7+, R = (C6H4)CONH(C6H5)) and a triply-S-bridged thiolato complex [((η6-cym)Ru)2(μ-S-RS)3]+ (8+), respectively. Coordination of Ru to the S atom in 7 allows formation of a strong H-bond (2.02 Å) between the en-NH and the carbonyl oxygen. To assess the possible effect of ruthenium coordination on the redox regulation of PTP1B, reactions of these thiolato products with H2O2 and/or GSH were then investigated, demonstrating that coordination to Ru largely retards both the oxidation (deactivation) of the thiol in compound 2 by H2O2 and the subsequent reduction (reactivation) of the sulfenyl-amide by GSH, implying that the inhibition of complex 1 on PTP1B (IC50 of 19 μM) may be attributed to coordination to its catalytic cysteine.
| Item Type: | Journal Article |
|---|---|
| Subjects: | Q Science > QD Chemistry Q Science > QP Physiology |
| Divisions: | Faculty of Science > Chemistry |
| Library of Congress Subject Headings (LCSH): | Organoruthenium compounds -- Therapeutic use, Organometallic compounds -- Therapeutic use, Antineoplastic agents, Biosynthesis, Catalysis |
| Journal or Publication Title: | Dalton Transactions |
| Publisher: | Royal Society of Chemistry |
| ISSN: | 1477-9226 |
| Date: | 21 November 2011 |
| Volume: | Vol.40 |
| Number: | No.43 |
| Page Range: | pp. 11519-11529 |
| Identification Number: | 10.1039/c1dt11189b |
| Status: | Peer Reviewed |
| Publication Status: | Published |
| Access rights to Published version: | Restricted or Subscription Access |
| Funder: | Guo jia zi ran ke xue ji jin wei yuan hui (China) [National Natural Science Foundation of China] (NSFC), China. Guo jia ke xue ji shu bu [Ministry of Science and Technology of China], Zhongguo ke xue yuan [Chinese Academy of Sciences] (CAS), European Research Council (ERC) |
| Grant number: | 90713020 (NSFC), 20975103 (NSFC), 21005081 (NSFC), 21020102039 (NSFC), 2007CB935601 (MOST), 2007CB935601 (MOST), 247450 (ERC) |
| References: | 1. P. C. A. Bruijnincx and P. J. Sadler, Curr. Opin. Chem. Biol., 2008, 12, 197. 2. P. C. A. Bruijnincx and P. J. Sadler, Adv. Inorg. Chem., 2009, 61, 1. 3. K. D. Camm, A. El-Sokkary, A. L. Gott, P. G. Stockley, T. Belyaeva and P. C. McGowan, Dalton Trans., 2009, 10914. 4. C. G. Hartinger and P. J. Dyson, Chem. Soc. Rev., 2009, 38, 391. 5. B. T. Loughrey, P. C. Healy, P. G. Parsons and M. L. Williams, Inorg. Chem., 2008, 47, 8589. 6. E. Meggers, G. E. Atilla-Gokcumen, K. Grundler, C. Frias and A. Prokop, Dalton Trans., 2009, 10882. 7. M. G. Mendoza-Ferri, C. G. Hartinger, R. E. Eichinger, N. Stolyarova, K. Severin, M. A. Jakupec, A. A. Nazarov and B. K. Keppler, Organometallics, 2008, 27, 2405. 8. J. Ruiz, C. Vicente, C. de Haro and D. Bautista, Dalton Trans., 2009, 5071. 9. C. Scolaro, A. Bergamo, L. Brescacin, R. Delfino, M. Cocchietto, G. Laurenczy, T. J. Geldbach, G. Sava and P. J. Dyson, J. Med. Chem., 2005, 48, 4161. 10. R. E. Aird, J. Cummings, A. A. Ritchie, M. Muir, R. E. Morris, H. Chen, P. J. Sadler and D. I. Jodrell, Br. J. Cancer, 2002, 86, 1652. 11. R. E. Morris, R. E. Aird, P. D. Murdoch, H. M. Chen, J. Cummings, N. D. Hughes, S. Parsons, A. Parkin, G. Boyd, D. I. Jodrell and P. J. Sadler, J. Med. Chem., 2001, 44, 3616. 12. F. Y. Wang, A. Habtemariam, E. P. L. van der Geer, R. Fernandez, M. Melchart, R. J. Deeth, R. Aird, S. Guichard, F. P. A. Fabbiani, P. Lozano-Casal, I. D. H. Oswald, D. I. Jodrell, S. Parsons and P. J. Sadler, Proc. Natl. Acad. Sci. U. S. A., 2005, 102, 18269. 13. Y. K. Yan, M. Melchart, A. Habtemariam and P. J. Sadler, Chem. Commun., 2005, 4764. 14. M. A. Bennett, M. J. Byrnes and I. Kovacik, J. Organomet. Chem., 2004, 689, 4463. 15. C. S. Allardyce, P. J. Dyson, D. J. Ellis and S. L. Heath, Chem. Commun., 2001, 1396. 16. H. K. Liu, F. Y. Wang, J. A. Parkinson, J. Bella and P. J. Sadler, Chem. Eur. J., 2006, 12, 6151. 17. T. Bugarcic, O. Novakova, A. Halamikova, L. Zerzankova, O. Vrana, J. Kasparkova, A. Habtemariam, S. Parsons, P. J. Sadler and V. Brabec, J. Med. Chem., 2008, 51, 5310. 18. H. M. Chen, J. A. Parkinson, S. Parsons, R. A. Coxall, R. O. Gould and P. J. Sadler, J. Am. Chem. Soc., 2002, 124, 3064. 19. C. Gossens, I. Tavernelli and U. Rothlisberger, J. Am. Chem. Soc., 2008, 130, 10921. 20. A. Frodl, D. Herebian and W. S. Sheldrick, J. Chem. Soc., Dalton Trans., 2002, 3664. 21. F. Y. Wang, H. M. Chen, J. A. Parkinson, P. D. Murdoch and P. J. Sadler, Inorg. Chem., 2002, 41, 4509. 22. F. Y. Wang, J. J. Xu, A. Habtemariam, J. Bella and P. J. Sadler, J. Am. Chem. Soc., 2005, 127, 17734. 23. W. B. Hu, Q. Luo, X. Y. Ma, K. Wu, J. A. Liu, Y. Chen, S. X. Xiong, J. P. Wang, P. J. Sadler and F. Y. Wang, Chem. Eur. J., 2009, 15, 6586. 24. S. Maity, S. Hattacharya and S. Chaudhury, Chemosphere, 2009, 77, 319. 25. H. Petzold, J. J. Xu and P. J. Sadler, Angew. Chem. Int. Ed., 2008, 47, 3008. 26. A. Ishii, K. Komiya and J. Nakayama, J. Am. Chem. Soc., 1996, 118, 12836. 27. K. Goto, M. Holler and R. Okazaki, J. Am. Chem. Soc., 1997, 119, 1460. 28. A. Salmeen, J. N. Andersen, M. P. Myers, N. K. Tonks and D. Barford, Mol. Cell, 2000, 6, 1401. 29. J. R. Wiener, J. A. Hurteau, B. J. M. Kerns, R. S. Whitaker, M. R. Conaway, A. Berchuck and R. C. Bast, Am. J. Obstet. Gynecol., 1994, 170, 1177. 30. J. R. Wiener, B. J. M. Kerns, E. L. Harvey, M. R. Conaway, J. D. Iglehart, A. Berchuck and R. C. Bast, J. Natl. Cancer Inst., 1994, 86, 372. 31. S. J. Liu, L. F. Zeng, L. Wu, X. Yu, T. Xue, A. M. Gunawan, Y. Q. Long and Z. Y. Zhang, J. Am. Chem. Soc., 2008, 130, 17075. 32. S. J. Liu, B. Zhou, H. Y. Yang, Y. T. He, Z. X. Jiang, S. Kumar, L. Wu and Z. Y. Zhang, J. Am. Chem. Soc., 2008, 130, 8251. 33. D. E. Moller, Nature, 2001, 414, 821. 34. R. H. van Huijsduijnen, A. Bombrun and D. Swinnen, Drug Discov. Today, 2002, 7, 1013. 35. R. H. van Huijsduijnen, W. H. B. Sauer, A. Bombrun and D. Swinnen, J. Med. Chem., 2004, 47, 4142. 36. M. Bentires-Alj and B. G. Neel, Cancer Res., 2007, 67, 2420. 37. A. Salmeen, J. N. Andersen, M. P. Myers, T. C. Meng, J. A. Hinks, N. K. Tonks and D. Barford, Nature, 2003, 423, 769. 38. B. K. Sarma and G. Mugesh, J. Am. Chem. Soc., 2007, 129, 8872. 39. S. Sivaramakrishnan, K. Keerthi and K. S. Gates, J. Am. Chem. Soc., 2005, 127, 10830. 40. R. L. M. van Montfort, M. Congreve, D. Tisi, R. Carr and H. Jhoti, Nature, 2003, 423, 773. 41. The IC50 value of inhibition of complex 1 against PTP1B was determined with p-nitrophenyl phosphate (pNPP) as a substrate, details was described in the Experimental section. More deteils will be published elsewhere. . 42. K. Waisser, M. Pesina, P. Holy, M. Pour, O. Bures, J. Kunes, V. Klimesova, V. Buchta, P. Kubanova and J. Kaustova, Arch. Pharm., 2003, 336, 322. 43. D. Barford, A. J. Flint and N. K. Tonks, Science, 1994, 263, 1397. 44. Y. Bae, W. D. Jang, N. Nishiyama, S. Fukushima and K. Kataoka, Mol. Biosyst., 2005, 1, 242. 45. F. Y. Wang, S. Weidt, J. J. Xu, C. L. Mackay, P. R. R. Langridge-Smith and P. J. Sadler, J. Am. Soc. Mass Spectrom., 2008, 19, 544. 46. T. Sriskandakumar, H. Petzold, P. C. A. Bruijnincx, A. Habtemariam, P. J. Sadler and P. Kennepohl, J. Am. Chem. Soc., 2009, 131, 13355. 47. H. Petzold and P. J. Sadler, Chem. Commun., 2008, 4413. 48. F. F. Prinsloo, J. J. Pienaar and R. Vaneldik, J. Chem. Soc. Dalton Trans., 1995, 3581. 49. K. J. Barnham, M. I. Djuran, P. S. Murdoch, J. D. Ranford and P. J. Sadler, Inorg. Chem., 1996, 35, 1065. 50. R. Y. C. Shin, J. J. Vittal, Z. Y. Zhou, L. L. Koh and L. Y. Goh, Inorg. Chim. Acta, 2003, 352, 220. 51. A. Correa, I. Tellitu, E. Dominguez and R. SanMartin, Org. Lett., 2006, 8, 4811. 52. J. Montalibet, K. I. Skorey and B. P. Kennedy, Methods, 2005, 35, 2. |
| URI: | http://wrap.warwick.ac.uk/id/eprint/40368 |
Actions (login required)
![]() |
View Item |
Tools
Tools

